Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines

Wuhan General Group (China), Inc.

401 Ryland St. Ste 200-A, Reno, NV 89502

_______________________________

+27 (82) 413 5457

https://m2bio.co/

willem@m2bio.co

SIC - 2833 - Medicinal and botanicals

QuarterlyReport

For the Period Ending: 30 September 2021

(the "Reporting Period")

As of 30 September 2021, the number of shares outstanding of our Common Stock was: 50,999,662

As of 30 June 2021, the number of shares outstanding of our Common Stock was: 55,289,662

As of 31 December 2020, the number of shares outstanding of our Common Stock was: 51,605,160

Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934):

Yes:

No:

Indicate by check mark whether the company's shell status has changed since the previous reporting period:

Yes:

No:

Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period:

Yes:

No:

  • "Change in Control" shall mean any events resulting in:
  1. Any "person" (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the "beneficial owner" (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company's then outstanding voting securities;
  2. The consummation of the sale or disposition by the Company of all or substantially all of the Company's assets;
  3. A change in the composition of the Board occurring within a two (2)-year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or
  4. The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)

Page 1 of 19

  1. Name and address(es) of the issuer and its predecessors (if any)

In answering this item, provide the current name of the issuer any names used by predecessor entities, along with the dates of the name changes.

03/2007 Wuhan General Group (China) Inc formely United National Film Corp.

The state of incorporation or registration of the issuer and of each of its predecessors (if any) during the past five years; Please also include the issuer's current standing in its state of incorporation (e.g. active, default, inactive):

09/12/2006 Nevada Active

Describe any trading suspension orders issued by the SEC concerning the issuer or its predecessors since inception:

NONE

List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:

NONE

The address(es) of the issuer's principal executive office:

Unit 01, Mason's Press, 7 Ravenscraig Road, Woodstock, 7925, Cape Town, South Africa

The address(es) of the issuer's principal place of business:

Check box if principal executive office and principal place of business are the same address:

Has the issuer or any of its predecessors been in bankruptcy, receivership, or any similar proceeding in the past five years?

Yes:

No:

If this issuer or any of its predecessors have been the subject of such proceedings, please provide additional details in the space below:

N/A

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)

Page 2 of 19

2)

Security Information

Trading symbol:

WUHN

Exact title and class of securities outstanding:

Common

CUSIP:

982569105

Par or stated value:

0.0001

Total shares authorized:

150,000,000

as of date: September 30, 2021

Total shares outstanding:

50,999,662

as of date: September 30, 2021

Number of shares in the Public Float2:

16,333,204

as of date: September 30,2021

Total number of shareholders of record:

156

as of date: September 30, 2021

All additional class(es) of publicly traded securities (if any):

Exact title and class of securities outstanding:

Preferred

Par or stated value:

0.0001

Total shares authorized:

50,000,000

as of date: September 30, 2021

Total shares outstanding:

15,000,000

as of date: September 30, 2021

Exact title and class of securities outstanding:

Warrants A

Par or stated value:

0.0001

Total shares authorized:

3,000,000

as of date: September 30, 2021

Total shares outstanding:

2,250,000

as of date: September 30, 2021

Exact title and class of securities outstanding:

Warrants B

Par or stated value:

0.0001

Total shares authorized:

3,000,000

as of date: September 30, 2021

Total shares outstanding:

710,000

as of date: September 30, 2021

Exact title and class of securities outstanding:

Warrants C

Par or stated value:

0.0001

Total shares authorized:

3,000,000

as of date: September 30, 2021

Total shares outstanding:

710,000

as of date: September 30, 2021

Exact title and class of securities outstanding:

Options A

Par or stated value:

0.0001

Total shares authorized:

3,000,000

as of date: September 30, 2021

Total shares outstanding:

1,000,000

as of date: September 30, 2021

Transfer Agent

Name:

EQ Shareowner Services

Phone:

303-282-4800

Email:

Michaelie.Wingo@equiniti.com

Address:

1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120

  • "Public Float" shall mean the total number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding (a "control person"), or any affiliates thereof, or any immediate family members of officers, directors and control persons.

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)

Page 3 of 19

Is the Transfer Agent registered under the Exchange Act?3 Yes:

No:

  1. Issuance History

The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstanding of any class of the issuer's securities in the past two completed fiscal years and any subsequent interim period.

Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events.

A. Changes to the Number of Outstanding Shares

Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods:

Shares Outstanding as of Second Most Recent

Fiscal Year End:

*Right-click the rows below and select "Insert" to add rows as needed.

Opening Balance

Date 01/01/2019

Common: 39,771,310

Preferred: 1,500,000

Warrant:

0

Option:

0

Date of

Transaction

Number of

Class of

Value of

Were the

Individual/ Entity

Reason for share

Restricted or

Exemption

Transaction

type (e.g. new

Shares

Securities

shares

shares

Shares were

issuance (e.g. for

Unrestricted

or

issuance,

Issued (or

issued

issued at

issued to

cash or debt

as of this

Registration

cancellation,

cancelled)

($/per

a discount

(entities must

conversion)

filing.

Type.

shares

share) at

to market

have individual

-OR-

returned to

Issuance

price at

with voting /

Nature of

treasury)

the time

investment

Services

of

control

Provided

issuance?

disclosed).

(Yes/No)

03/01/2019

New issuance

2,500,000

common

.004

yes

Slingshot

debt conversion

Unrestricted

Exemption

Marketing

Solutions, LLC

(Benjamin Barry)

08/29/2019

New issuance

1,000,000

common

.004

yes

Slingshot

debt conversion

Unrestricted

Exemption

Marketing

Solutions, LLC

(Benjamin Barry)

09/23/2019

New issuance

1,500,000

preferred

.0001

no

Ramy Kamaneh

management

Restricted

Exemption

09/23/2019

New issuance

6,000,000

preferred

.0001

no

Jeff Robinson

management

Restricted

Exemption

  • To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act.

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)

Page 4 of 19

09/23/2019

New issuance

6,000,000

preferred

.0001

no

Dr. Anna Morera

management

Restricted

Exemption

Leralta

02/26/2020

New issuance

4,283,850

common

.004

yes

Slingshot

debt conversion

Unrestricted

Exemption

Marketing

Solutions, LLC

(Benjamin Barry)

05/05/2020

New issuance

500,000

common

.03

no

StockVest (Art

Consulting

Restricted

Exemption

Brent)

services

05/21/2020

New issuance

50,000

common

.03

no

William Selah

Consulting

Restricted

Exemption

Abrams

services

09/29/2020

New issuance

100,000

common

.10

yes

Ronald Hargrove

Private Placement

Restricted

Exemption

09/29/2020

New issuance

50,000

common

.10

yes

Robert Thomas

Private Placement

Restricted

Exemption

Hooper

09/30/2020

New issuance

150,000

common

.10

yes

Clark Winkler

Private Placement

Restricted

Exemption

10/01/2020

New issuance

75,000

common

.10

yes

Allen Robert Tripp

Private Placement

Restricted

Exemption

10/01/2020

New issuance

125,000

common

.10

yes

Clyde L Blanchi

Private Placement

Restricted

Exemption

10/01/2020

New issuance

200,000

common

.10

yes

John Walters

Private Placement

Restricted

Exemption

10/02/2020

New issuance

100,000

common

.10

yes

Philip J

Private Placement

Restricted

Exemption

Munschauer

10/07/2020

New issuance

50,000

common

.10

yes

Ted Vruggink

Private Placement

Restricted

Exemption

10/08/2020

New issuance

150,000

common

.10

yes

Timothy Jay

Private Placement

Restricted

Exemption

Nagelkirk

10/08/2020

New issuance

50,000

common

.10

yes

Taylor Blom

Private Placement

Restricted

Exemption

10/15/2020

New issuance

75,000

common

.10

yes

Michael David

Private Placement

Restricted

Exemption

Ware

12/09/2020

New issuance

350,000

common

.10

yes

Jeffrey J Krueger

Private Placement

Restricted

Exemption

12/10/2020

New issuance

250,000

common

.10

yes

Brian Corday

Private Placement

Restricted

Exemption

12/27/2020

New issuance

150,000

common

.10

yes

John Wolters

Private Placement

Restricted

Exemption

12/27/2020

New issuance

125,000

common

.10

yes

Ronald Hargrove

Private Placement

Restricted

Exemption

12/29/2020

New issuance

1,500,000

common

.30

yes

ThreeD Capital

Private Placement

Restricted

Exemption

( Sheldon

Inwentash)

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)

Page 5 of 19

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Wuhan General Group (China) Inc. published this content on 19 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 November 2021 20:03:06 UTC.